1. Recent progress in the discovery and development of DNA gyrase B inhibitorsMichaela Barančokova, Danijel Kikelj, Janez Ilaš, 2018, pregledni znanstveni članek Ključne besede: antibacterial, ATP-competitive, DNA gyrase, drug discovery, Gram-negative bacteria, GyrB, inhibitor, Par, topoisomerase II, topoisomerase IV
Celotno besedilo (datoteka, 717,37 KB) Gradivo ima več datotek! Več... |
2. A fine-tuned lipophilicity/hydrophilicity ratio governs antibacterial potency and selectivity of bifurcated halogen bond-forming NBTIsAnja Kolarič, Maja Kokot, Martina Hrast, Matjaž Weiss, Irena Zdovc, Jurij Trontelj, Simon Žakelj, Marko Anderluh, Nikola Minovski, 2021, izvirni znanstveni članek Ključne besede: antibacterials, drug discovery, DNA gyrase inhibitors, topoisomerase IV inhibitors, intercalators, novel bacterial topoisomerase inhibitors, topoisomerase II inhibitors, intercalating agents
Celotno besedilo (datoteka, 6,80 MB) Gradivo ima več datotek! Več... |
3. Cell models for Alzheimer’s and Parkinson’s diseaseSandra Cetin, Damijan Knez, Stanislav Gobec, Janko Kos, Anja Pišlar, 2022, pregledni znanstveni članek Ključne besede: neurodegenerative diseases, cell models, cytotoxicity assays, drug discovery, drug screening
Celotno besedilo (datoteka, 1,65 MB) Gradivo ima več datotek! Več... |
4. Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesisMatic Proj, Martina Hrast, Gregor Bajc, Rok Frlan, Anže Meden, Matej Butala, Stanislav Gobec, 2023, izvirni znanstveni članek Ključne besede: fragment-based drug discovery, hit triage, inhibitors, antibacterial agents
Celotno besedilo (datoteka, 1,79 MB) Gradivo ima več datotek! Več... |
5. Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bondsAnja Kolarič, Thomas Germe, Martina Hrast, Clare E. M. Stevenson, David M. Lawson, Nicolas P. Burton, Judit Vörös, Anthony Maxwell, Nikola Minovski, Marko Anderluh, 2021, izvirni znanstveni članek Ključne besede: antibacterials, DNA gyrase inhibitors, drug discovery, Staphylococcus aureus, intercalators, novel bacterial topoisomerase inhibitors, NBTIs, symmetrical bifurcated halogen bonds, crystal structure, novel NBTIs mechanism of action, antimicrobials, DNA-binding proteins, drug development, X-ray crystallography
Celotno besedilo (datoteka, 2,00 MB) Gradivo ima več datotek! Več... |
6. Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testingLarisa Tratnjek, Nadica Sibinovska, Slavko Kralj, Darko Makovec, Katja Kristan, Mateja Erdani-Kreft, 2021, izvirni znanstveni članek Ključne besede: esophageal adenocarcinoma, FLO-1 cell line, disease pathophysiology, biological techniques, cancer, cell biology, diseases, drug discovery, engineering, oncology
Celotno besedilo (datoteka, 16,48 MB) Gradivo ima več datotek! Več... |
7. Small-Molecule Galectin Ligands: Structure-Based Optimisation of Affinity and SelectivitySjors Van Klaveren, 2024, doktorsko delo/naloga Ključne besede: Galectins, ligands, inhibitors, drug discovery, molecular dynamics simulations, virtual screening, docking studies, structure-activity relationship, X-ray crystallography.
Celotno besedilo (datoteka, 20,83 MB) |
8. Biolayer interferometry and its applications in drug discovery and developmentAna Jug, Tomaž Bratkovič, Janez Ilaš, 2024, pregledni znanstveni članek Ključne besede: biosensor, drug discovery, library screening, label-free analysis, kinetics, affinity, biopharmaceutical development
Celotno besedilo (datoteka, 1,22 MB) Gradivo ima več datotek! Več... |
